Table 1 Characteristics of patient AML samples.
From: Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia
Patient | Dose (mg) | Age/sex | Diagnosis | Stage | Antigen expression | ras status |
|---|---|---|---|---|---|---|
B | 100 | 59 M | M5, de novo AML | Relapse | CD34+, CD33+ | WT |
A | 300 | 75 M | M4, de novo AML | New | CD34+, CD33+ | WT |